TIMOTHY COX: Open Payments
NPI 1437642170 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 43 payments from 11 companies in 2025. Trend: 2023 $854 · 2024 $969 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $226 |
| Corcept Therapeutics | 11 | $157 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Novo Nordisk Inc | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Amgen Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Medtronic, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: Korlym, AIRSUPRA, FARXIGA, JARDIANCE, TRELEGY ELLIPTA, Ozempic, REPATHA, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
